Pfizer Inc. (PFE)
28.34
-0.23
(-0.81%)
USD |
NYSE |
Aug 26, 09:34
Pfizer EPS Diluted (Quarterly) : -0.0435 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0435 |
| March 31, 2026 | 0.4688 |
| December 31, 2025 | -0.2898 |
| September 30, 2025 | 0.6197 |
| June 30, 2025 | 0.5056 |
| March 31, 2025 | 0.5196 |
| December 31, 2024 | 0.0707 |
| September 30, 2024 | 0.784 |
| June 30, 2024 | 0.0042 |
| March 31, 2024 | 0.5477 |
| December 31, 2023 | -0.592 |
| September 30, 2023 | -0.424 |
| June 30, 2023 | 0.4077 |
| March 31, 2023 | 0.9677 |
| December 31, 2022 | 0.8692 |
| September 30, 2022 | 1.509 |
| June 30, 2022 | 1.728 |
| March 31, 2022 | 1.367 |
| December 31, 2021 | 0.5883 |
| September 30, 2021 | 1.425 |
| June 30, 2021 | 1.021 |
| March 31, 2021 | 0.8614 |
| December 31, 2020 | 0.1496 |
| September 30, 2020 | 0.2608 |
| June 30, 2020 | 0.6209 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5975 |
| December 31, 2019 | -0.0609 |
| September 30, 2019 | 1.36 |
| June 30, 2019 | 0.89 |
| March 31, 2019 | 0.68 |
| December 31, 2018 | -0.07 |
| September 30, 2018 | 0.69 |
| June 30, 2018 | 0.65 |
| March 31, 2018 | 0.59 |
| December 31, 2017 | 2.02 |
| September 30, 2017 | 0.47 |
| June 30, 2017 | 0.51 |
| March 31, 2017 | 0.51 |
| December 31, 2016 | 0.13 |
| September 30, 2016 | 0.22 |
| June 30, 2016 | 0.33 |
| March 31, 2016 | 0.49 |
| December 31, 2015 | -0.03 |
| September 30, 2015 | 0.34 |
| June 30, 2015 | 0.42 |
| March 31, 2015 | 0.38 |
| December 31, 2014 | 0.1948 |
| September 30, 2014 | 0.4164 |
| June 30, 2014 | 0.4516 |
| March 31, 2014 | 0.3491 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Merck & Co., Inc. | -0.5405 |
| Bristol Myers Squibb Co. | 1.620 |
| Viatris, Inc. | -0.1021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -246.00M |
| Revenue (Quarterly) | 15.03B |
| Total Expenses (Quarterly) | 15.29B |
| Enterprise Value | 214.62B |
| Gross Profit Margin (Quarterly) | 62.94% |
| Profit Margin (Quarterly) | -1.64% |
| Earnings Yield | 2.66% |
| Operating Earnings Yield | 10.46% |
| Normalized Earnings Yield | 8.549 |